Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
NCT00036309 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2006-07-19
Summary
The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment.
Conditions
- Depressive Disorder
Interventions
- DRUG
-
Duloxetine Hydrochloride
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-05-31
- Completion
- 2003-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder
NCT00191061 ·Status: COMPLETED ·Phase: PHASE4
-
Duloxetine vs. Active Comparator in the Treatment of Patients With Depression
NCT00071695 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Duloxetine in Elderly Patients With Major Depressive Disorder
NCT00062673 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain
NCT00191919 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine vs. Active Comparator for the Treatment of Depression
NCT00067912 ·Status: COMPLETED ·Phase: PHASE4
-
Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression
NCT00494377 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients
NCT00536471 ·Status: COMPLETED ·Phase: PHASE4
-
Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder
NCT00122863 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
NCT00849901 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
NCT00849693 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
NCT00437125 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression
NCT00296699 ·Status: COMPLETED ·Phase: PHASE4
-
Switching to Duloxetine in Patients With Depression
NCT00696774 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
NCT00406848 ·Status: COMPLETED ·Phase: PHASE4
-
Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain
NCT00036335 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain Injury
NCT01223001 ·Status: TERMINATED ·Phase: PHASE2
-
Duloxetine Versus Paroxetine for Major Depression
NCT00489775 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine in the Treatment of Melancholic Depression
NCT00191685 ·Status: COMPLETED ·Phase: PHASE3
-
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
NCT00479726 ·Status: COMPLETED ·Phase: PHASE4
-
Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
NCT00375973 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Duloxetine for Chronic Depression: a Double-blind Study
NCT00360724 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
NCT00422162 ·Status: COMPLETED ·Phase: PHASE4
-
Duloxetine Versus Placebo in Chronic Low Back Pain
NCT00424593 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Neurobiology of Depression
NCT01051466 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression
NCT03559192 ·Status: COMPLETED ·Phase: PHASE2